EyePoint Pharmaceuticals Inc

NASDAQ:EYPT   11:32:26 AM EDT
13.89
+0.25 (+1.83%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)957.38M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.46 Million
Adjusted EPS-$0.77
See more estimates
10-Day MA$13.38
50-Day MA$11.36
200-Day MA$8.24
See more pivots

EyePoint Pharmaceuticals Inc Stock, NASDAQ:EYPT

480 Pleasant Street, Suite A-210, Watertown, Massachusetts 02472
United States of America
Phone: +1.617.926.5000
Number of Employees: 165

Description

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.